Use of antimüllerian hormone: the risks of interpreting ovarian reserve markers in isolation

Reflections on “Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimüllerian hormone” by Toner et al.

Like Comment

Authors

Zev Rosenwaks, M.D., David E. Reichman, M.D.

Volume 99, Issue 7, Pages 1850, June 2013

Abstract

Reflections on “Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimüllerian hormone” by Toner et al.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00452-4/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.